1. Benelli, R., Adatia, R., Ensoli, B., Stetler-Stevenson, W.G., Santi, L., Albini, A. (1994). Inhibition of AIDS-Kaposi’s sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol. Res. 6, 251–257.
2. Chae, Y.M., Park, K.K., Magae, J., Lee, I.S., Kim, C.H., Kim, H.C., Hong, S., Lee, J.G., Choi, I.J., Chang, Y.C., et al. (2004). Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation. Biochem. Biophys. Res. Commun. 319, 550–555.
3. Chambers, A.F., and Matrisian, L.M., (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 260–270.
4. Cho, B.J., Im, E.K., Kwon, J.H., Lee, K.H., Shin, H.J., Oh, J., Kang, S.M., Chung, J.H., and Jang, Y. (2005). Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol. Cells 20, 429–434.
5. Cho, H.J., Kang, J.H., Kwak, J.Y., Lee, T.S., Lee, I.S., Park, N.G., Nakajima, H., Magae, J., and Chang, Y.C. (2007). Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28, 1104–1110.